The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
(1999) · PubMed · Cited by 2,204
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J.-W., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,215
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 879
Xu, R.-H., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., & Huang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.613.65.2 · Cited by 835
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
(2001) · PubMed · Cited by 557
RIDER, M. H., BERTRAND, L., VERTOMMEN, D., MICHELS, P. A., ROUSSEAU, G. G., & HUE, L. (2004) · Biochemical Journal · doi:10.1042/bj20040752 · Cited by 440
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Self-citationEnzymology of Cancer Cells: (Second of Two Parts)
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703102961005 · Cited by 416
Marsin, A.-S., Bouzin, C., Bertrand, L., & Hue, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205213200 · Cited by 379
Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 370
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate
Okar, D. A., Lange, A. J., Manzano, À., Navarro-Sabatè, A., Riera, L., & Bartrons, R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01699-6 · Cited by 357
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Ramanathan, A., Wang, C., & Schreiber, S. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502267102 · Cited by 357
Atsumi, T., Chesney, J. A., Metz, C. N., Leng, L., Donnelly, S. C., Makita, Z., Mitchell, R., & Bucala, R. (2002) · PubMed · Cited by 323
Self-citationVan Schaftingen, E., Hue, L., & Hers, H. G. (1980) · Biochemical Journal · doi:10.1042/bj1920897 · Cited by 317
Chesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiegel, L., Al-Abed, Y., Han, J. H., Metz, C., & Bucala, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3047 · Cited by 287
Self-citationA unique glucose-dependent apoptotic pathway induced by c-Myc
Shim, H., Chun, Y. S., Lewis, B. C., & Dang, C. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1511 · Cited by 286
Hypoxia, glucose metabolism and the Warburg’s effect
Bartrons, R., & Caro, J. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9080-3 · Cited by 260
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.
Van Schaftingen, E., Jett, M. F., Hue, L., & Hers, H. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3483 · Cited by 246
Minchenko, O., Opentanova, I., & Caro, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01179-7 · Cited by 236
Van Schaftingen, E., Hue, L., & Hers, H.-G. (1980) · Biochemical Journal · doi:10.1042/bj1920887 · Cited by 212
Williams, A. C., Collard, T. J., & Paraskeva, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202660 · Cited by 196
Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand
Bauer, D. E., Harris, M. H., Plas, D. R., Lum, J. J., Hammerman, P. S., Rathmell, J. C., Riley, J. L., & Thompson, C. B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1001fje · Cited by 187
Boren, J., Cascante, M., Marin, S., Comı́n-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W.-N. P., & Boros, L. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105796200 · Cited by 182
Fructose‐2,6‐bisphosphate and control of carbohydrate metabolism in eukaryotes
Okar, D. A., & Lange, A. J. (1999) · BioFactors · doi:10.1002/biof.5520100101 · Cited by 178
Blum, R., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · PubMed · Cited by 178
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Self-citationBlum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.999.65.3 · Cited by 161
Characterization of a Human Placental Fructose-6-Phosphate, 2-Kinase/Fructose- 2,6 - Bisphosphatase
Sakakibara, R., Kato, M., Okamura, N., Nakagawa, T., Komada, Y., Tominaga, N., Shimojo, M., & Fukasawa, M. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021719 · Cited by 152
Carrot and stick: HIF-α engages c-Myc in hypoxic adaptation
Huang, E. L. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402302 · Cited by 143
Minamoto, T., Mai, M., & Ronai, Z. A. (2000) · PubMed · Cited by 141
Calvo, M., Bartrons, R., Castaño, E., Perales, J. C., Navarro‐Sabaté, À., & Manzano, À. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.093 · Cited by 124
Mazurek, S., Zwerschke, W., Jansen‐Dürr, P., & EIGENBRODT, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204792 · Cited by 122
K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts
Vizán, P., Boros, L. G., Figueras, A., Capellá, G., Mangues, R., Bassilian, S., Lim, S. K., Lee, W. P., & Cascante, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0074 · Cited by 119
Hue, L., Beauloye, C., Marsin, A.-S., Bertrand, L., Horman, S., & Rider, M. H. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2063 · Cited by 107
Wu, C., Khan, S. A., Peng, L.-J., & Lange, A. J. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.010 · Cited by 91
Vora, S., Halper, J. P., & Knowles, D. M. (1985) · PubMed · Cited by 91
Boros, L. G., Torday, J. S., Lim, S., Bassilian, S., Cascante, M., & Lee, W. N. (2000) · PubMed · Cited by 90
HIF‐1: hypoxia‐inducible factor or dysoxia‐inducible factor?
López‐Lázaro, M. (2006) · The FASEB Journal · doi:10.1096/fj.05-5168hyp · Cited by 85
Regulation of the regulatory enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
Okar, D. A., Wu, C., & Lange, A. J. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.006 · Cited by 80
Manzano, À., Rosa, J. L., Ventura, F., Pérez, J. X., Nadal, M., Estivill, X., Ambrosio, S., Gil, J., & Bartrons, R. (1998) · Cytogenetic and Genome Research · doi:10.1159/000015181 · Cited by 79
Boros, L. G., Bassilian, S., Lim, S. K., & Lee, W. P. (2001) · Pancreas · doi:10.1097/00006676-200101000-00001 · Cited by 78
Hue, L., & Rousseau, G. G. (1993) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(93)90011-2 · Cited by 75
Hamilton, J. A., Callaghan, M. J., Sutherland, R. L., & Watts, C. K. W. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.4.9909 · Cited by 74
Sánchez-Martínez, C., & Aragón, J. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00496-1 · Cited by 69
Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality
Chesney, J. A., Telang, S., Yalçın, A., Clem, A. L., Wallis, N. K., & Bucala, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.193 · Cited by 64
Self-citationWang, Q., Donthi, R. V., Wang, J., Lange, A. J., Watson, L. J., Jones, S. P., & Epstein, P. N. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.91501.2007 · Cited by 63
Sakai, A., Kato, M., Fukasawa, M., Ishiguro, M., Furuya, E., & Sakakibara, R. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021270 · Cited by 61
Glycolytic Enzymes in Breast Cancer, Benign Breast Disease and Normal Breast Tissue
Hennipman, A. H., Smits, J., van Oirschot, B. A., van Houwelingen, H. C., Rijksen, G., Neyt, J. P., Unnik, J. A. M. V., & Staal, G. E. J. (1987) · Tumor Biology · doi:10.1159/000217529 · Cited by 60
Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts
Kole, H. K., Resnick, R. J., Van Doren, M., & Racker, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90084-v · Cited by 57
Glycolytic Enzyme Activities in Breast Cancer Metastases
Hennipman, A., van Oirschot, B. A., Smits, J., Rijksen, G., & Staal, G. E. J. (1988) · Tumor Biology · doi:10.1159/000217568 · Cited by 56
Boscá, L., Mojena, M., Ghysdael, J., Rousseau, G. G., & Hue, L. (1986) · Biochemical Journal · doi:10.1042/bj2360595 · Cited by 54
Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain
Keßler, R., & Eschrich, K. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00014-6 · Cited by 53
Staal, G. E. J., Ottenhoff-Kalff, A. E., Heesbeen, E. C., Veelen, C. W. M. V., & Rijksen, G. (1987) · PubMed · Cited by 50
Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells
Riera, L., Manzano, À., Navarro‐Sabaté, À., Perales, J. C., & Bartrons, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00169-6 · Cited by 49
Navarro‐Sabaté, À., Manzano, À., Riera, L., Rosa, J. L., Ventura, F., & Bartrons, R. (2001) · Gene · doi:10.1016/s0378-1119(00)00591-6 · Cited by 42
The discovery and the biological role of fructose 2,6-bisphosphate
Hers, H. G. (1984) · Biochemical Society Transactions · doi:10.1042/bst0120729 · Cited by 40
Riera, L., Obach, M., Navarro‐Sabaté, À., Duran, J., Perales, J. C., Viñals, F., Rosa, J. L., Ventura, F., & Bartrons, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00808-1 · Cited by 35
Watanabe, F., Sakai, A., & Furuya, E. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010001.x · Cited by 33
Tissue Distribution of Placenta-Type 6-Phosphofructo- 2-kinase/Fructose-2,6-bisphosphatase
Sakakibara, R., Okudaira, T., Fujiwara, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0429 · Cited by 28
Evolutionary analysis of fructose 2,6‐bisphosphate metabolism
Michels, P. A. M., & Rigden, D. J. (2006) · IUBMB Life · doi:10.1080/15216540600688280 · Cited by 28
Activation of 6-phosphofructo-2-kinase by pp60v-src is an indirect effect
Marchand, M. J., Maisin, L., Hue, L., & Rousseau, G. G. (1992) · Biochemical Journal · doi:10.1042/bj2850413 · Cited by 13
Cited by
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,551
Self-citationTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Rodríguez-Prados, J.-C., Través, P. G., Cuenca, J., Rico, D., Aragonés, J., Martín-Sanz, P., Cascante, M., & Boscá, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901698 · Cited by 1,022
Metadata
- Authors
- Yalcin, A., Telang, S., Clem, B., & Chesney, J.
- Venue
- Experimental and Molecular Pathology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 86
- Issue
- 3
- Pages
- 174-179
- ISSN
- 0014-4800 (ISSN-L)
- OpenAlex
- W1989760304
- Cited by
- 405
- References
- 71
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.